Oestrogen receptor (ER) is expressed in approximately 60%-70% of human breast cancer. Clinical trials and retrospective analyses have shown that ER-positive (ER+) tumours are more tolerant to chemotherapeutic drug resistance than ER-negative (ERÀ) tumours. In addition, isobavachalcone (IBC) is known as a kind of phytoestrogen with antitumour effect. However, the underlying mechanism of IBC in ER+ breast cancer needs to be elucidated further. Our in vitro experiments showed that IBC could attenuate 17b-estradiol (E 2 )-induced paclitaxel resistance and that E 2 could stimulate CD44 expression in ER+ breast cancer cells but not in ERÀ cells.
However, the underlying mechanism of chemotherapeutic drug resistance in ER+ breast cancer has not yet been elucidated. 17b-Estradiol (E 2 ) can regulate and maintain a series of physiological processes, such as reproduction, CNS development and metabolic balance. 8 Many cellular responses to E 2 are mediated by oestrogen receptors (ERs), including ERa and ERb. Although clinical and experimental data have confirmed the key role of ERa in breast cancer, the role of ERb in breast cancer remains controversial. 8, 9 Recent studies have demonstrated that expression of ERa can prevent paclitaxel-induced apoptosis in breast cancer MCF-7 cells. 10, 11 ERa can act as a nuclear receptor and regulate target gene transcription via the "classical" model or the "nonclassical" model. 12 In addition to its role in the "classical" model of gene regulation through oestrogen response elements (EREs) in promoter regions, ERa can form protein complexes with other transcription factors, such as Sp1, Ap1 and NF-jB, to regulate gene transcription involved in the "nonclassical" model. [12] [13] [14] These observations suggest that ERa can regulate a large variety of genes that are associated with the development of chemotherapy resistance in ER+ breast cancer cells.
Psoralen, a traditional Chinese herb, is isolated from dried ripe fruits of leguminous Psoralea corylifolia L. [15] [16] [17] It is warm natured and pungent flavoured, with the effect of enriching the kidney and strengthening yang. 18 Recent studies have shown that psoralen has some biological functions, such as blood vessel dilatation, myocardial contractility enhancement and antifungal, anticancer and oestrogenlike effects. 19 Modern pharmacological studies have also shown that isobavachalcone (IBC), an important component of psoralen, has strong antibacterial, antioxidant, anti-reverse transcriptase, antitubercular and anticancer abilities. 20, 21 Previous studies have reported that IBC inhibits tumour formation in mouse skin cancer and induces apoptosis in neuroblastoma. 22, 23 However, the potential functions of IBC in cancer-related treatment need further study.
CD44 and CD24 are characteristic of the cancer stem cell phenotype, and these molecules are closely associated with poor prognosis and chemotherapy resistance in cancer. [24] [25] [26] [27] Recently, natural substances from plants have been documented as effective intervention agents in the down-regulation of CD44/CD24 expression in experimental breast carcinoma. 28 
| Stepwise selection of cells
We simulated the development of resistance in clinics by weekly for each dose of paclitaxel tested.
| Cell viability assay
ZR-75-1 and MCF-7 cells were seeded at 5000 cells per well in 96-well plates and then treated with the indicated concentrations of paclitaxel (72 hours) or E 2 /IBC (48 hours). Subsequently, the cells were treated with 10 lL MTT (5 mg/mL) at 37°C for 4 hours followed by 150 lL dimethyl sulphoxide, and cell viability was determined by measuring the absorbance at 570 nm using a microplate reader (Bio-Rad, California, USA).
| RNA isolation and real-time PCR
Total RNA was isolated using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. Approximately 1 lg of extracted RNA was reverse transcribed to cDNA using random primers. Realtime PCR was performed with cDNA using SYBR green (TOYOBO).
The primers used were as follows: CD44 (forward 5 0 -CGCTATGTC 
| Western blotting
Total protein was extracted from cultured cells, subjected to 8%-12% SDS-polyacrylamide gel electrophoresis and transferred onto 0.45-lm PVDF membranes (Millipore). The membranes were then blocked with 5% milk-TBST for 1 hour and incubated with primary antibodies against CD44 (diluted 1:1000), ERa (diluted 1:1000), P-gp (diluted 1:1000) and b-actin (diluted 1:5000 in TBST) overnight.
After incubation with appropriate secondary antibodies for 1 hour at room temperature, the membranes were detected by Tanon 5200
Imaging System (Shanghai, China).
| Clonogenic cell survival assay
Cells suspended in fresh culture medium were plated at a density of 400 cells/well onto 6-cm plates and incubated for 24 hours and then cultured in fresh medium containing 5 nmol/L paclitaxel. At the end of 2 weeks of incubation, the cells were fixed with cold methanol and stained with crystal violet (Beyotime, China) for 20 minutes at room temperature. Thereafter, the plates were gently washed with water and allowed to air-dry. All experiments were performed in triplicate.
| Flow cytometry assay
Approximately 10 
| Statistical analysis
Each of the experiments was repeated at least three times. Values are expressed as the mean AE SD of triplicate measurements unless otherwise noted. Student's paired t test was used to analyse differences between the sample of interest and its control. P < .05 was considered statistically significant.
| RESULTS

| IBC decreased resistance of ER+ breast cancer to paclitaxel
Although oestrogen can maintain biological functions in breast can- Figure 2H ). Colony formation assay showed that fewer paclitaxel-resistant colonies were formed in the si-CD44 group, which was, than in the control group ( Figure 2I ). These data suggested that CD44 expression might be involved in the resistance to paclitaxel-mediated E 2 stimulation.
| ERa induced by E 2 enhanced CD44 expression in breast cancer cells
Our previous study showed that ERa was essentially involved in chemoresistance, which may be attributed to its role as a nuclear transcriptional factor in regulating some important tumour drugresistant genes. 10 Thus, we detected the expression of ERa in ER+ CD44 is closely associated with chemotherapeutic drug resistance in cancer cells. Previous studies have revealed that CD44 is highly expressed in triple-negative breast cancer (TNBC) and correlated with poor survival of TNBC patients. 42 Of note, CD44 also plays a key role in ER+ breast cancer, resulting in poor prognosis and radiotherapy resistance. 42 However, the role of CD44 in drug resistance of ER+ breast cancer is worth studying in depth. Interestingly, in this study, 
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